This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Nipro Corporation, Nipro Corporaton. Active years: 2010-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2017
Title: Yu Ishima - Innovator in Bilirubin Excretion Enhancement
Introduction
Yu Ishima is an inventor based in Kumamoto-shi, Japan. He is known for his innovative approach to addressing hyperbilirubinemia through the development of a bilirubin excretion enhancer. His work focuses on creating a novel therapy method that aims to improve the excretion of bilirubin in patients suffering from this condition.
Latest Patent Applications
Yu Ishima has filed a patent application for a bilirubin excretion enhancer. The invention comprises a serum albumin domain II-like protein that includes a serum albumin subdomain IIA as its active ingredient. In one embodiment, the serum albumin subdomain IIA features an amino acid sequence of SEQ ID NO: 1. Additionally, the serum albumin domain II-like protein may be a serum albumin domain II, which comprises the amino acid sequence of SEQ ID NO: 4. This innovative approach aims to provide a therapeutic solution for individuals with elevated bilirubin levels.
Conclusion
Yu Ishima's contributions to the field of bilirubin excretion enhancement represent a significant step forward in the treatment of hyperbilirubinemia. His dedication to developing effective therapies showcases the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile